REQUEST A DEMO
Total
USD $0.00
Search more companies

Real Pharm Group Sp. z o.o. (Poland)

Main Activities: Electronic Shopping and Mail-Order Houses
Secondary Activities: All Other Food Manufacturing | All Other General Merchandise Stores | Other Miscellaneous Store Retailers | Other Direct Selling Establishments | Traveler Accommodation | All Other Traveler Accommodation
Full name: Real Pharm Group Sp. z o.o. Profile Updated: January 21, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Real Pharm Group Sp. z o.o. is an enterprise located in Poland, with the main office in Czaplinek. The company operates in the Electronic Shopping and Mail-Order Houses industry. The company was established on November 24, 2022. The latest financial highlights indicate a net sales revenue increase of 6.36% in 2024. A growth of 21.49% was recorded in its total assets. Real Pharm Group Sp. z o.o.’s net profit margin decreased by 9.16% in 2024.

Headquarters
Ul. Szkolna 41
Czaplinek; Mazowieckie; Postal Code: 05-530

Contact Details: Purchase the Real Pharm Group Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Real Pharm Group Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Real Pharm Group Sp. z o.o. report to view the information.
Incorporation Date:
November 24, 2022
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
91%
Company Performance
Financial values in the chart are available after Real Pharm Group Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
6.36%
Total operating revenue
7%
Operating profit (EBIT)
-56.43%
EBITDA
-55.17%
Net Profit (Loss) for the Period
-58.64%
Total assets
21.49%
Total equity
4.17%
Operating Profit Margin (ROS)
-9.06%
Net Profit Margin
-9.16%
Return on Equity (ROE)
-26.98%
Debt to Equity Ratio
22.16%
Quick Ratio
-0.15%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?